Motivation: DNA methylation can be used to identify functional changes at transcriptional enhancers and other cis-regulatory modules (CRMs) in tumors and other primary disease tissues. Our R/Bioconductor package ELMER (Enhancer Linking by Methylation/Expression Relationships) provides a systematic approach that reconstructs gene regulatory networks (GRNs) by combining methylation and gene expression data derived from the same set of samples.
. A ELMER interactions. B Groups U and M definition in (un)supervised mode. C BRCA supervised analysis: Candidate MRs. D Chromatin state enrichment analysis: enrichment for enhancer active region, weak enhancer and active promoter region for MCF-7 cell. E TFs ranking for the FOXA3 motif. The top 3 most anti-correlated TFs (FOXA1, GATA3 and ESR1 ), and all TF classified by TFClass database in the same (sub)family are highlighted.
Supervised vs Unsupervised mode

21
ELMER is designed to identify differences between two sets of samples within a given dataset. In 22 original version (Yao et al., 2015) , the first step -identification of differentially methylated CpG 23 probes (DMCs) -was hard-coded to identify DMCs between non-cancer vs. cancer samples, and the 24 subsequent step was unsupervised, identifying changes within any subset of tumors. In ELMER 2.0, 25 we generalize these strategies so that they are applicable to any paired dataset, including disease vs. 26 healthy tissue for any disease type. 27 In the Unsupervised mode, as in ELMER 1.0, for each comparison samples from two most 28 extreme quintiles based on DNA methylation levels were used, generating both the M (methylated) 29 and the U (unmethylated) groups. In the new Supervised mode, the U and M groups are defined 30 strictly by sample group labels, and all samples in each group are used. The Supervised mode can 31 greatly increase statistical power ( Fig. 1B) . 32 Characterization of chromatin state context of enriched probes 33 To provide possible functional interpretation of the regulatory elements identified by ELMER, we 34 perform chromatin state enrichment analysis of identified probes, using statehub.org data (Coetzee 35 et al., 2018) . Enrichment of chromatin states is calculated against a background model that uses the 36 distal probe set from which the candidate probes are drawn from (Fig. 1C) . In addition to the details below, a complete HTML output report for the two runs described in the Use 95 case Section is available at http://bit.ly/ELMER_reports. This document contains all source code, 96 parameters used, Methods descriptions, output tables, and output plots. 97 ELMER workflow 98 The complete ELMER workflow is shown in Supplementary Fig. 1 Supplementary Fig 1. ELMER workflow: ELMER receives as input a DNA methylation array object and a gene expression object (matrices or SummarizedExperiment objects) and a Genomic Ranges (GRanges) object with distal probes to be used as filter which can be retrieved using the get.feature.probe function. The function createMAE will create a Multi Assay Experiment object keeping only samples that have both DNA methylation and gene expression data. Genes will be mapped to genomic position and annotated using ENSEMBL database (Aken et al., 2016) , while for probes it will add annotation from Zhou et al. (http://zwdzwd.github.io/InfiniumAnnotation) . This MAE object will be used as input to the next analysis functions. First, it identifies differentially methylated probes followed by the identification of their nearest genes (10 upstream and 10 downstream) through the get.diff.meth and GetNearGenes functions respectively. For each probe, it will verify if any of the nearby genes were affected by its change in the DNA methylation level and a list of gene and probes pairs will be outputted from get.pair function. For the probes in those pairs, it will search for enriched regulatory Transcription Factors motifs with the get.enriched.motif function. Finally, the enriched motifs will be correlated with the level of the transcription factor through the get.TFs function. In the figure green Boxes represents user input data, blue boxes represent output object, orange boxes represent auxiliary pre-computed data and gray boxes are functions.
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Main differences between ELMER old version (v.1) and the new version (v.2)
100
The main differences between ELMER old version (v.1) and the new version (v.2) is summarized in the 101 Supplementary Table S1 . To perform ELMER analyses, we populate a MultiAssayExperiment with a DNA methylation matrix 111 or SummarizedExperiment object from HM450K or EPIC platform; a gene expression matrix or 112 SummarizedExperiment object for the same samples; a matrix mapping DNA methylation samples to 113 gene expression samples; and a matrix with sample metadata (i.e. clinical data, molecular subtype, etc.). 114 TCGA or other GDC data can be imported by TCGAbiolinks ( Supplementary Figure 1) , in which case 115 the necessary data structures will be automatically created. Based on the genome of samples selected, 116 metadata for the DNA methylation probes, such as genomic coordinates, will be added from (Zhou et al., 117 2016); and metadata for gene annotation is added from the ENSEMBL database (Yates et al., 2015) 118 using biomaRt (Durinck et al., 2009 ). Use of these standardized import packages allows ELMER 2.0 to 119 take advantage of all current datasets. For instance, TCGABiolinks will soon be able to read from the 120 International Cancer Genome Consortium (ICGC) repository, and similar importers can be written for 121 other disease databanks.
102
122
If using non-TCGA data, the matrix with sample metadata should be provided with at least a 123 column with a patient identifier and another one identifying its group which will be used for analysis, if 124 samples in the methylation and expression matrices are not ordered and with same names, a matrix ELMER is designed to identify differences between two sets of samples within a given dataset. In Yao 138 et al., the first step (identification of DMCs) was hard-coded to identify DMCs between non-cancer vs. 139 cancer samples, and the subsequent step was unsupervised, identifying changes within any subset of 140 tumors. In ELMER 2.0, we generalize these strategies so that they are applicable to any paired dataset, 141 including disease vs. healthy tissue for any disease type, untreated vs. treated samples, etc. We now 142 support two modes, with the Unsupervised based on the method of Yao et al.. Here, the user defines 143 Group 1 and Group 2 samples, but an assumption is made that only a subset of samples differs between 144 the two groups. By default, this subset includes the most extreme 20% of samples within the group.
145
While the 20% is an input parameter that can be changed to any value, this was the setting used in Yao 146 et al., which was able to identify molecular cancer subtypes such as ER-positive tumors within the 147 complete set of TCGA breast cancer cases. The new mode is the Supervised mode, in which all available 148 samples from each group are used. This mode should be used when pre-determined phenotypes or 149 molecular subtypes are known in advance, such as the treated vs. untreated case. The advantage is that 150 this greatly increases statistical power because of all samples from each group. This can be extremely 151 important, given the large burden of multiple hypothesis testing involved in ELMER.
152
The first step is the identification of differentially methylated CpGs (DMCs). In the Supervised mode, 153 we compare the DNA methylation level of each distal CpG for all samples in Group 1 compared to all 154 samples Group 2, using an unpaired one-tailed t-test. In the Unsupervised mode, the samples of each 155 group (Group 1 and Group 2) are ranked by their DNA methylation beta values for the given probe, and 156 those samples in the lower quintile (20% samples with the lowest methylation levels) of each group are 157 used to identify if the probe is hypomethylated in Group 1 compared to Group 2. The reverse applies for 158 the identification of hypermethylated probes. It is important to highlight that in the Unsupervised mode, 159 each probe selected may be based on a different subset the samples, and thus probe sets from multiple 160 molecular subtypes may be represented. In the supervised mode, all tests are based on the same set of 161 samples.
162
The 20% is a parameter to the diff.meth function called minSubgroupFrac. For the unsupervised 163 analysis, this is set to 20% as in Yao et al. (2015) , because we wanted to be able to detect a specific 164 molecular subtype among samples; these subtypes often make up only a minority of samples, and 20% 165 was chosen as a lower bound for the purposes of statistical power (high enough sample numbers to yield 166 t-test p-values that could overcome multiple hypotheses corrections, yet low enough to be able to capture 167 changes in individual molecular subtypes occurring in 20% or more of the cases.) This number can be set 168 as an input to the diff.meth function and should be tuned based on sample sizes in individual studies. In 169 the Supervised mode, where the comparison groups are implicit in the sample set and labeled, the 170 minSubgroupFrac parameter is set to 100%. An example would be a cell culture experiment with 5 171 replicates of the untreated cell line, and another 5 replicates that include an experimental treatment.
172
To identify hypomethylated DMCs, a one-tailed t-test is used to rule out the null hypothesis: 173 µ group1 ≥ µ group2 , where µ group1 is the mean methylation within the lowest group 1 quintile (or another 174 percentile as specified by the minSubgroupFrac parameter) and µ group2 is the mean within the lowest 175 group 2 quintile. Raw p-values are adjusted for multiple hypothesis testing using the 176 Benjamini-Hochberg method (Benjamini and Hochberg, 1995) , and probes are selected when they had 177 adjusted p-value less than 0.01 (which can be configured using the pvalue parameter). For additional 178 stringency, probes are only selected if the methylation difference: ∆ = µ group1 − µ group2 was greater 179 than 0.3. The same method is used to identify hypermethylated DMCs, except we use the upper quintile, 180 and the opposite tail in the t-test is chosen.
181
Identification of putative target gene(s) 182
For each differentially methylated distal probe (DMC), the closest 10 upstream genes and the closest 10 183 downstream genes are tested for inverse correlation between methylation of the probe and expression of 184 the gene, which is the same basic strategy employed in ELMER version 1. However, we now import all 185 gene annotations programmatically using the Biomart (Durinck et al., 2005 (Durinck et al., , 2009 package. This allows 186 easy extensibility to use any annotations desired (our default uses Ensembl annotations).
187
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This step also differs between the Supervised and Unsupervised modes. In the Unsupervised mode, as 188 in ELMER 1.0, for each probe-gene pair, the samples (all samples from both groups) are divided into 189 two groups: the M group, which consist of the upper methylation quintile (the 20%of samples with the 190 highest methylation at the enhancer probe), and the U group, which consists of the lowest methylation 191 quintile (the 20% of samples with the lowest methylation). In the new Supervised mode, the U and M 192 groups are defined strictly by sample group labels, and all samples in each group are used. The
193
Supervised mode can greatly increase statistical power, as illustrated in Supplementary Figure 2 . 194 For each differentially methylated distal probe (DMC), the closest 10 upstream genes and the closest 195 10 downstream genes are tested for inverse correlation between methylation of the probe and expression 196 of the gene (the number 10 can be changed using the numFlankingGenes parameter). To select these 197 genes, the probe-gene distance is defined as the distance from the probe to the transcription start site 198 specified by the ENSEMBL gene level annotations (Yates et al., 2015) accessed via the R/Bioconductor 199 package biomaRt (Durinck et al., 2005 (Durinck et al., , 2009 . By choosing a constant number of genes to test for each 200 probe, our goal is to avoid systematic false positives for probes in gene rich regions. This is especially 201 important given the highly non-uniform gene density of mammalian genomes.
202
Thus, exactly 20 statistical tests were performed for each probe, as follows.
203
For each candidate probe-gene pair, the Mann-Whitney U test is used to test the null hypothesis that 204 overall gene expression in group M is greater than or equal than that in group U . This non-parametric 205 test was used in order to minimize the effects of expression outliers, which can occur across a very wide 206 dynamic range. For each probe-gene pair tested, the raw p-value P r is corrected for multiple hypothesis 207 using a permutation approach as follows. The gene in the pair is held constant, and x random 208 methylation probes are chosen to perform the same one-tailed U test, generating a set of x permutation 209 p-values P p . We chose the x random probes only from among those that were "distal" (farther than 2kb 210 from an annotated transcription start site), in order to draw these null-model probes from the same set 211 as the probe being tested (Sham and Purcell, 2014 ). An empirical p-value P e value was calculated using 212 the following formula (which introduces a pseudo-count of 1):
Notice that in the Supervised mode, no additional filtering is necessary to ensure that the M and U 214 group segregate by sample group labels. The two sample groups are segregated by definition, since these 215 probes were selected for their differential methylation, with the same directionality, between the two 216 groups. Because ELMER can now search essentially all probes on the array, it is important to understand the 224 context of the probes that result from an ELMER analysis. Typically these are enhancer probes, but 225 some regulatory changes may involve promoters, insulators, etc. We used the StateHub (Coetzee et al., 226 2017) and FunciVar Bioconductor packages to characterize enrichment of the various cell-type-specific 227 chromatin states in the significant BRCA-hypomethylated probes (Supplementary Figures 3, 4) .
228
Importantly, the MCF-7 cell line, and ER-positive breast cancer cell line, is much more strongly enriched 229 for all enhancer and promoter classes than other cell types. As more reference cell types become 230 available, this analysis will be useful in characterizing tumor GRN changes that reflect particular cell 231 types or co-opted developmental programs.
232
All methods are described here: https://www.simoncoetzee.com/bioc2017.html FunciVar by 233 default calculates a likelihood based on the beta-binomial distribution, returning a 95% credible interval 234 (optionally set by the "CI" argument) for the range of differences between the two populations of 235 variants (i.e. foreground and background). Specifically it calculates a distribution of true enrichment (as 236 probability of overlap) for both sets of variants in the genomic features based on the observed number of 237 overlaps:
for S successes in N trials. FunciVar uses an uninformative Jeffreys prior c(a=0.5, b=0.5) to compare 239 the two distributions directly by subtracting permuted samples to obtain the distribution of differences. 240 The prior can be overridden in special cases. 241 Supplementary Fig 3. For each probe set tested (i.e. the set of all probes occurring in significant probe-gene pairs), we 250 quantify enrichments using Fisher's exact test (where a is the number of probes within the selected 251 probe set that contains one or more motif occurrences; b is the number of probes within the selected 252 probe set that do not contain a motif occurrence; c and d are the same counts within the entire array 253 probe set drawn from the same set of distal-only probes using the same definition as the primary 254 analysis) and multiple testing correction with the Benjamini-Hochberg procedure (Fisher, 1922) .
255
A probe set was considered significantly enriched for a particular motif if the 95% confidence interval 256 of the Odds Ratio was greater than 1.1 (specified by option lower.OR, 1.1 is default), the motif occurred 257 at least 10 times (specified by option min.incidence, 10 is default) in the probe set and F DR < 0.05.
258
Identification of master regulator TFs
259
When a group of enhancers is coordinately altered in a specific sample subset, this is often the result of 260 an altered upstream master regulator transcription factor in the gene regulatory network. ELMER 261 identifies master regulator TFs corresponding to each of the TF binding motifs enriched from the 262 previous analysis step. For each enriched motif, ELMER takes the mean DNA methylation of all distal 263 probes (in significant probe-gene pairs) that contain that motif occurrence (within a ±250bp region) and 264 compares this mean DNA methylation to the expression of each gene annotated as a human TF.
265
In the Unsupervised mode, a statistical test is performed for each motif-TF pair, as follows. All 266 samples are divided into two groups: the M group, which consists of the 20% of samples with the highest 267 average methylation at all motif-adjacent probes, and the U group, which consisted of the 20% of 268 samples with the lowest methylation. This step is performed by the get.TFs function, which takes 269 minSubgroupFrac as an input parameter, again with a default of 20%. For each candidate motif-TF pair, 270 the Mann-Whitney U test is used to test the null hypothesis that overall gene expression in group M is 271 greater or equal than that in group U . This non-parametric test was used in order to minimize the 272 effects of expression outliers, which can occur across a very wide dynamic range. For each motif tested, 273 this results in a raw p-value (P r ) for each of the human TFs.
274
The new Supervised mode uses the same approach as described for the identification of putative 275 target gene(s) step. The U and M groups are one of the the label group of samples and the 276 minSubgroupFrac parameter is set to 100% to use all samples from both groups in the statistical test.
277
This also can result in greater statistical power when using the Supervised mode.
278
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Comparing inferred results with MCF-7 ChIA-PET 279 As in our earlier paper, we compared CRM / gene pairs identified by Unsupervised analysis of TCGA 280 Breast Cancer cases to chromatin loops derived from deep-sequenced ChIA-PET data from ER+ Breast 281 Cancer MCF7 cells Li et al. (2012) . ELMER pairs were enriched for ChIA-PET loops by roughly 3-fold 282 over random pairs, consistent with our earlier results ( Supplementary Fig. 5 ).
283
First, we identify the number of ELMER pairs overlapping the ChIA-PET loops, then we repeat 284 using randomly generated pairs with properties similar to the ELMER pairs. For each true ELMER 285 probe in a probe-gene pair, we randomly select a different probe from the complete set of distal probes. 286 We then choose the nth nearest gene to the random probe, where n is the same as the adjacency of the 287 true ELMER probe (i.e. if the true probe is linked to the second gene upstream, the random probe will 288 also be linked to its second gene upstream). Thus, the random linkage set has both the same number of 289 probes and the same number of linked genes as the true set. One hundred such random datasets were 290 generated to arrive at a 95% CI (±1.96 * SD). The result is shown in Supplementary Fig. 5 . Of the 2118 291 putative pairs identified in breast cancer tumors, 223 (≈ 10.75%) were also identified as loops in the 292 MCF7 ChIA-PET data. This was a three-fold enrichment over randomized probe-gene pairs.
293 Supplementary Fig 5. The graph shows the comparison of the number of probe-gene pairs identified within MCF7 ChIA-PET data using the putative pairs from BRCA vs. random pairs.
Graphical User Interface
294
To enable user access to the methodologies offered in ELMER and to give users the flexibility of 295 point-and-click style analysis without the need to learn R, we have implemented a full graphical user 296 interface (GUI) through the R/Bioconductor package TCGAbiolinksGUI (Silva et al., 2017) available at 297 http://bioconductor.org/packages/TCGAbiolinksGUI/. This tool allows definition of sample 298 groupings based on user-defined clinical attributes in the supported databanks, including TCGA and 299 TARGET, and GDC. A tutorial detailing the steps needed to use the tools through the GUI is available 300 at https://bioinformaticsfmrp.github.io/Bioc2017.TCGAbiolinks.ELMER/index.html 301 Supplementary Figures 6,7 and 8 shows the three ELMER menus in the R/Bioconductor 302 TCGAbiolinksGUI package.
303 Supplementary Fig 6. ELMER graphical user interface in TCGAbiolinksGUI: MAE creation menu. Supplementary Fig 10. Single HTML file output report example, showing generation of the genome browser plot.
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Use Case 1: Breast Invasive Carcinoma (Unsupervised mode) 313 We performed ELMER analysis comparing 778 Breast Invasive Carcinoma (Primary solid tumor) 314 samples to 83 samples of normal tissue adjacent to the tumor In this use case we wanted to be able to 315 detect non pre-determined molecular subtypes among the tumor samples, so the percentage of samples 316 used to identify the differentially methylated probes in function get.diff.meth was set to 20% and the 317 mode in function get.pair and in function get.TFs which was set to "unsupervised". In this mode we 318 define the U (unmethylated) group as the samples with lowest quintile of DNA methylation levels and 319 the M (methylated) group as the highest quintile.
320
This analysis showed that the set of hypomethylated CpG probes (DMCs) in the tumors and linked 321 to the expression of a nearby gene ( Supplementary Figure 11) had an enrichment for TFBS motifs for 322 FOX family transcription factors (FOXA2, FOXA3, FOXA1, etc.) (Supplementary Figure 12) . For the 323 most highly enriched motif FOXA3, the master regulator analysis identified FOXA1 as the top candidate 324 among all TFs in the human genome ( Supplementary Figure 13) , with the collaborating factors GATA3 325 and ESR1 as the next best candidates (Supplementary Figure 14) . This illustrates the important point 326 that in vitro defined motifs from public TFBS databases are not always bound by the same TF family 327 member in vivo. This was the same result of the analysis in Yao et al., where we showed that ELMER 328 identification of FOXA1, GATA3, and ESR1 were driven specifically by the ER+ (luminal A and Master Regulators for the other Breast Cancer molecular subtypes, such as Basal-like, HER2+, etc.
331 Supplementary Fig 11. The comprehensive heatmap view shows all probe / gene pairs identified by ELMER, clustered according to similarity. This plot is based on the Unsupervised analysis of Breast Invasive Carcinoma (Primary solid tumor) samples to 83 samples of normal tissue adjacent to the tumor (Solid Tissue Normal). The inverse correlation between methylation and expression can be observed. 
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336
We performed pairwise analysis comparing known molecular subtypes (Her2, Luminal A, Luminal B 337 and Basal-like) using the TCGA BRCA dataset and classifications retrieved from Ciriello et al. (2015) . 338 Supplementary Table S2 shows the number of samples of each molecular subtype of breast cancer and 339 Supplementary Table S3 summarizes the candidate MRs identified.
340
The unsupervised analysis of the same sample identified several Luminal type Master Regulators 341 (MRs) such as FOXA1, GATA3, and ESR1. In order to identify MRs for the other subtypes, we created 342 a table (Table S3) modification, but also reduces the time to identify possible platform specific problems. iv) the 361 documentation has been revised and improved by changing the format of a PDF presentation to an 362 HTML-navigable page ( Supplementary Fig. 15 Precision Tower 5810 Intel (R) Xeon (R) of RAM, CPU E5-1650 v3 @ 3.50GHz, using 10 cores for code 368 parallelization. The times for each one of the main functions are shown in Supplementary Table S4 .
369
Some functions had an increase in the time due to changes either in the data or method. As the 370 number of TF binding models used in this new version increased from 91 to 771 it was expected that the 371 function get.TFs would increase the time to run, as more iterations will be performed. Also, the 372 enriched.motif now performs and fisher test for each motif increasing the time to execute the function. 373 Overall ELMER v2 decrease in 55% the time to run the analysis compared to ELMER v1. The code 374 used to run ELMER v2 is the same provided in the HTML reports and the code to run ELMER v1 can 375 be found in this gist (https://gist.github.com/tiagochst/04c2c61b1f3f34f892cd0d0e12a81be6). 376 Also, Supplementary Table S5 shows the time required to run each ELMER supervised analysis. Only 377 runs that executed all functions were included, that means, if a analysis was not able to identify 378 differential methylated probes it was excluded from the table. Although the larger the number of 379 samples the longer the execution time, it is worth remembering that the unsupervised mode uses all 380 samples in all the steps, while the supervised mode uses only a quintile of samples in each groups which 381 will reduce its run time. It is assumed in the unsupervised mode that for at least one of the groups the samples belong to more 384 than one molecular subtypes while in the supervised mode the assumption is that both groups have 385 samples belonging to only one molecular subtype. For example, the unsupervised mode is more useful to 386 perform analysis such as Normal vs Primary Solid Tumors, and the supervised LumA vs Basal-like.
382
387
To better explain the output of both modes, considering the hypothetical heatmap below 388 (Supplementary Figure 16 ) and comparing the cell group (cell1, cell2, cell3) vs Normal, the unsupervised 389 mode, which will use 20% of the samples, will identify all unmethylated regions (blue regions) and 390 identify the anti-correlation with the gene expression (lost DNA methylation and the distal gene 391 increased the expression). The next functions will identify the candidate master regulator TF that might 392 be binding to those regions and activating the distal gene. But, that TF will be specific for only one 393 molecular subtype and not all of them. Thus, it is expected that the unsupervised mode returns a general 394 list of TF activated in group 1, but we are not able to differ in which molecular subtype it is activated. 395 The supervised mode will solve that problem by comparing all samples from cell1 vs all Normal samples. 396 Another drawback of the unsupervised mode is that regions specific to a certain molecular subtype might 397 be not be identified if the number of samples is very low (i.e. 5% of all samples).
398 Supplementary Fig 16. Auxiliary heatmap for unsupervised mode vs Supervised explanation.
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